Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Double-blind, multicenter, randomized trial to compare the effect of two doses of adrenocorticotropic hormone versus placebo in controlling delayed emesis after high-dose cisplatin in adult patients with cancer.
Passalacqua R, Cocconi G, Caminiti C, Silingardi V, Bella MA, Bichisao E, Michiara M, Malavasi V, Donati D, Di Costanzo F, Rocca A, Di Sarra S, Scaglione F, Fraschini F. Passalacqua R, et al. Among authors: di costanzo f, di sarra s. J Clin Oncol. 1997 Jun;15(6):2467-73. doi: 10.1200/JCO.1997.15.6.2467. J Clin Oncol. 1997. PMID: 9196163 Clinical Trial.
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
Roila F, Tonato M, Basurto C, Bella M, Passalacqua R, Morsia D, DiCostanzo F, Donati D, Ballatori E, Tognoni G, et al. Roila F, et al. J Clin Oncol. 1987 Jan;5(1):141-9. doi: 10.1200/JCO.1987.5.1.141. J Clin Oncol. 1987. PMID: 3543234 Clinical Trial.
Low-dose aminoglutethimide with and without hydrocortisone replacement as a first-line endocrine treatment in advanced breast cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Cocconi G, Bisagni G, Ceci G, Bacchi M, Boni C, Brugia M, Carpi A, Di Costanzo F, Franciosi V, Gori S, et al. Cocconi G, et al. Among authors: di costanzo f. J Clin Oncol. 1992 Jun;10(6):984-9. doi: 10.1200/JCO.1992.10.6.984. J Clin Oncol. 1992. PMID: 1588379 Clinical Trial.
Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
Roila F, Tonato M, Basurto C, Picciafuoco M, Bracarda S, Donati D, Malacarne P, Monici L, Di Costanzo F, Patoia L, et al. Roila F, et al. Among authors: di costanzo f. J Clin Oncol. 1989 Nov;7(11):1693-700. doi: 10.1200/JCO.1989.7.11.1693. J Clin Oncol. 1989. PMID: 2681556 Clinical Trial.
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Cocconi G, Bella M, Zironi S, Algeri R, Di Costanzo F, De Lisi V, Luppi G, Mazzocchi B, Rodinò C, Soldani M, et al. Cocconi G, et al. Among authors: di costanzo f. J Clin Oncol. 1994 Dec;12(12):2687-93. doi: 10.1200/JCO.1994.12.12.2687. J Clin Oncol. 1994. PMID: 7989945 Clinical Trial.
High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer. A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Di Costanzo F, Tagliaventi M, Carlini P, Zironi S, Mazzocchi B, Bella M, Donati D, Acito L, Maggian P, Angiona S. Di Costanzo F, et al. Am J Clin Oncol. 1996 Jun;19(3):307-10. doi: 10.1097/00000421-199606000-00021. Am J Clin Oncol. 1996. PMID: 8638548 Clinical Trial.
High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
Di Costanzo F, Gasperoni S, Malacarne P, Belsanti V, Luppi G, Marzola M, Corgna E, Sdrobolini A, Passalacqua R, Figoli F, Algeri R, Zironi S, Angiona S, Boni C. Di Costanzo F, et al. Am J Clin Oncol. 1998 Aug;21(4):369-75. doi: 10.1097/00000421-199808000-00011. Am J Clin Oncol. 1998. PMID: 9708636 Clinical Trial.
Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized study.
Cocconi G, Bisagni G, Bella M, Acito L, Anastasi P, Carpi A, Di Costanzo F, Frassoldati A, Mosconi A, Borrini A, Buzzi P. Cocconi G, et al. Among authors: di costanzo f. Am J Clin Oncol. 1999 Dec;22(6):593-600. doi: 10.1097/00000421-199912000-00010. Am J Clin Oncol. 1999. PMID: 10597744 Clinical Trial.
190 results